Rohini Kandhari
Biographic Data
| ID | 1713708 |
|---|---|
| NAME | Rohini Kandhari |
| GIVEN NAMES | Rohini |
| FAMILY NAME | Kandhari |
| SIGNATURE | KANDHARI R |
| AFFILIATIONS | Jawaharlal Nehru University |
| ORCID | 0000-0002-4949-3809 |
| VERIFIED | Yes |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| AUTHOR COUNT | 2 |
| EDITOR COUNT | 0 |
| FIRST PUBLICATION YEAR | 2021 |
| LATEST PUBLICATION YEAR | 2023 |
| H-INDEX | 0 |
‘Good’ and ‘bad’ stem cell research
In this article, I explore the opinions of India's stem cell scientists on unproven and unregulated stem cell treatment provision in the country's private health sector. Drawing on interviews, I describe three themes, namely ethical responsibility; exaggerated timelines for stem cell cures; and the scientific method to demonstrate how scientists make distinctions between themselves as producers of ‘good stem cell research’ and treatment providers…
Stem Cell Treatments in India
In this article I explore how experimental stem cell treatments have become a therapeutic choice in India. Drawing on ethnographic fieldwork, I illustrate six sociotechnical pathways by which clinically unproven treatment is rendered regular health care practice for consumers and providers across the country. Through each pathway, based on the themes of bioconsumption, integration, consumer contacts, treatment experience and rituals, and politica…
No prominent works on this page.
Stem Cell Treatments in India
In this article I explore how experimental stem cell treatments have become a therapeutic choice in India. Drawing on ethnographic fieldwork, I illustrate six sociotechnical pathways by which clinically unproven treatment is rendered regular health care practice for consumers and providers across the country. Through each pathway, based on the themes of bioconsumption, integration, consumer contacts, treatment experience and rituals, and politica…
‘Good’ and ‘bad’ stem cell research
In this article, I explore the opinions of India's stem cell scientists on unproven and unregulated stem cell treatment provision in the country's private health sector. Drawing on interviews, I describe three themes, namely ethical responsibility; exaggerated timelines for stem cell cures; and the scientific method to demonstrate how scientists make distinctions between themselves as producers of ‘good stem cell research’ and treatment providers…
Biomedical Ethics and Regulation (2 works) · Neuroethics, Human Enhancement, Biomedical Innovations (2 works) · Political science (2 works) · Public relations (2 works) · Sociology (2 works) · Anthropology (1 works) · Biology (1 works) · Economics (1 works) · Engineering (1 works) · Engineering ethics (1 works)